.jpg)
Biocan DHPPI + L Vaccine against canine distemper, inf. laryngotracheitis, inf. hepatitis, parvovirosis, parainfluenza vivid and leptospirosis (L. icterohaemorrhagiae inact., L. canicola inact., L. grippotyphosa inact.) in dogs
Composition - 1 ml:
Component DHPPi (freeze-dried):
Virus febris contagiosae canis min. 103,0 TCID50, max.104,5 TCID50
Virus laryngotracheitidis contagiosae canis min. 103,5 TCID50, max.104,5TCID50
Parvovirus enteritidis canis min. 104,5 TCID50, max.105,5TCID50
Virus parainfluensis canis min. 103,0 TCID50, max.104,2 TCID50
Nutrimentum pro lyophilisatione ad 1 ml
Component L (solution):
Leptospira icterohaemorrhagiae inact. min. 1 x 107,0, max. 1 x 109,0
Leptospira canicola inact. min. 1 x 107,0, max. 1 x 109,0
Leptospira grippotyphosa inact. min. 1 x 107,0, max. 1 x 109,0
Algeldrati suspensio. Nutrimentum ad cultivationem leptospirae
Drug form:
Solution for injection
Immunological properties:
After application of the vaccine to the animals body, antigens contained in the vaccine are identified as foreign particles and this is followed by activation of a large number of protection mechanisms in organism (macrophages, opsonins, interleukins, B-lymphocytes etc.), in result of which specific antibodies against antigen determinants contained in the vaccine are formed. These specific antibodies should prevent development of the disease in the event of infection.
Immunity is starting after 14 days after first vaccination and firm immunity is developed after further 14 days after re-vaccination. Primovaccinated animals are revaccinated at an interval of 14 - 21 days. Annual revaccination is recommended to maintain immunity.
Indication:
For the active immunization of dogs against distemper, infectious hepatitis, infectious laryngotracheitis, parvovirosis, parainfluenza and the most frequently occurred leptospira serovars in dogs at the age of 8 weeks and above.
Target Species
Dog
Bioveta